Skip to search.
 FTSE 100 Down 0.29%

MannKind Corp. (MNKD)

-NasdaqGM
0.62 Up 0.02(3.63%) 30 Sep 21:00
|After Hours: : 0.62 0.00 (0.00%) 1 Oct 00:59
Prev Close:0.60
Open:0.59
Bid:0.60 x 6500
Ask:0.63 x 1800
1y Target Est:0.15
Beta:2.29025
Earnings Date:7 Nov - 11 Nov (Est.)
Day's Range:0.57 - 0.63
52wk Range:0.55 - 3.79
Volume:3,940,839
Avg Vol (3m):3,247,190
Market Cap:296.39m
P/E (ttm):N/A
EPS (ttm):-0.85
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for MNKD at this time.

Comparison

Symbol% ChgMkt Cap
MNKDUp 3.63%296.39m
LLYUp 0.65%84.70b
GSKUp 0.54%102.67b
NVODown 0.50%104.36b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.23
Quarterly EPS Est (Sep-16) :-0.05
Mean Recommendation*:3.8
PEG Ratio (5 yr expected):-0.10

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes patients in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback